In the Dutch studies presented here, we found the same fivefold variation, even after adjustment for age. These differences might be explained by different characteristics of the studied populations, but this raises the question of what these (unknown) characteristics might be to cause such tremendous variation. Different methods, leading to varying degrees of overestimation ofhypertension, seems a more probable hypothesis. The present study aims to make sense of all studies published since 1970 about hypertension in The Netherlands. We tried to correct for methodological variation, to arrive at a best possible estimate of the prevalence of hypertension, and at an estimate of changes in this prevalence over time.
Conclusions -The strong variation in prevalence is explained by methodology and by a period effect indicating a decrease of the prevalence of hypertension over time. Whether this decrease is true or caused by confounding due to unknown or unreported methodological variation over time is unknown. For future studies, a standardised method could reduce the influence of methodological variables and thereby the variation in reported prevalences.
Hypertension is an important risk factor for cardiovascular disease, the major killer in low mortality countries of the developed world.' Moreover, blood pressure is modifiable, and treatment to lower it reduces the risk of cardiovascular disease in hypertensive patients. 2 Hence, hypertension is an important target for health policy, confronting the policy maker with two types of questions: * How many people are hypertensive, and is there an indication that these numbers are changing over time? * What will be the expected effects of preventive interventions, and how should these be monitored? Both questions seem straightforward and easy to answer: measure the blood pressure over several points in time, estimate the modifiable fraction, and calculate the population attributable risk and the potential impact fraction.34
There have been a number of surveys which included blood pressure measurement, so prevalence data seem readily available. But are they really? Blood pressure measurement does not ask for sophisticated equipment, but to yield reliable results a very stringent standardised method has to be adopted since there are several factors that can influence a blood pressure measurement.56 The reported prevalence of hypertension varies tremendously between and within countries.7 In the Dutch studies presented here, we found the same fivefold variation, even after adjustment for age. These differences might be explained by different characteristics of the studied populations, but this raises the question of what these (unknown) characteristics might be to cause such tremendous variation. Different methods, leading to varying degrees of overestimation ofhypertension, seems a more probable hypothesis. The present study aims to make sense of all studies published since 1970 about hypertension in The Netherlands. We tried to correct for methodological variation, to arrive at a best possible estimate of the prevalence of hypertension, and at an estimate of changes in this prevalence over time.
Methods

CRITERIA FOR SELECTION OF STUDIES
All data published since 1970 about the prevalence of hypertension in The Netherlands were collected. Few are published in peer reviewed papers, most were identified through the snowball method (checking references in all detected publications) and expert advice. We found 13 studies reporting the prevalence of hypertension in The Netherlands. To be included in this analysis, age specific prevalences should be reported for at least two age groups for both men and women. This excluded two studies. Of the remaining 11 studies, three were identified in publications in scientific journals, four in reports from various registers, and four in PhD theses.
DATA ANALYSIS
The data were analysed using a logistic model with the presence or absence of hypertension van de Mheen, Bonneux, Gunning-Schepers Table 1 Overview of studies that report prevalences of hypertension by age and sex in The Netherlands 
Results
In table 1 some characteristics of the selected studies are described, along with the reported prevalences in each of the studies. Almost all studies define hypertension as a systolic blood pressure above 160 mmHg or a diastolic blood pressure above 95 mmHg, or both. The reported prevalences vary considerably, even between studies that used comparable methods, as for instance EPOZ" and RIVM. '5 In the first analysis we quantified the extent of the differences between studies, adjusted for age. We estimated that the age adjusted prevalence in COPIH10 was seven times higher in men and five times higher in women than PreTensie.'7 The EPOZ" study reported prevalences that were four and five times higher than those reported in the CB heart project9 for men and women respectively. Lelystad,'6 on the other hand, reported prevalences for men that were about the same as those from the CB heart project,9 but were four times higher for women. 
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